Macrolides in the Treatment of Respiratory Diseases in Children Caused by Extra- and Intracellular Microorganisms
Journal Title: Здоров`я дитини - Year 2014, Vol 4, Issue 55
Abstract
Activity of macrolides in the most common bacterial infections that cause acute respiratory infections in children is considered. Data on high efficacy of macrolides, spectrum of their safety, in particular, josamycin and its soluble form for enteral application Wilprafen® Solutab, are provided.
Authors and Affiliations
Ye. I. Yulish, O. Yu. Pantofelman
Keywords
Related Articles
- EP ID EP311980
- DOI -
- Views 72
- Downloads 0
Pathogenetic Reasoning of Administration of Mucolytic Agents for Respiratory Diseases in Children
The paper presents the mechanisms of cough and bronchial obstruction in lesions of the respiratory tract of various origins. The effect of microbial biofilms on the course of diseases was considered particularly. The met...
Features of renal dysfunction in children with systemic lupus erythematosus and juvenile idiopathic arthritis
Background. In systemic autoimmune diseases of the connective tissue, kidney damage in some cases is a syndrome of the disease, and in others, it is a consequence of the underlying process. Objective: to establish the in...
Biofilm The Formation in Respiratory Diseases. Influence of Ambroxol on Airway Biofilms (Literature Review)
This article reviews the literature on the development of biofilms on airway in respiratory diseases and the impact of ambroxol on them. Since biofilm infections respond poorly to standard antibiotic therapy, their treat...
Annular Pancreas Associated with TORCH-infection
The article presents follow-up in a newborn child with a congenital malformation of the gastrointestinal tract (annular pancreas), III degree prematurity against the background of persistent cytomegalovirus and toxoplasm...
Somatic Health Status of Infants with Down Syndrome
In order to improve the medical surveillance of infants with Down syndrome, an analysis of developmental features of 35 children aged from 1 month to 3 years with Standard Trisomy 21 has been carried out. A high rate of...